Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions
Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions News provided by Share this article Share this article NEW YORK, May 4, 2021 /PRNewswire/ -- U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for direct application system and method for the delivery of bioactive compositions and formulations. The invention utilizes a "repeated motion" delivery technology (AQT Technology), creating a new route of administration ...
Sobin Chang David Shafer Aquavit Pharmaceuticals Inc Technology Officer New Drug Applications Biologics License Applications
Source: prnewswire.com